Taipei, Feb. 14 (CNA) A COVID-19 vaccine made in Taiwan by Medigen Vaccine Biologics Corp. has received emergency use authorization (EUA) in Paraguay after the unblinding of a Phase 3 clinical trial conducted in the South American country, the company said in a statement Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in CORONAVIRUS
- Serious COVID-19 cases up 30% as Taiwan enters 4th Omicron wave: CDCThe number of serious COVID-19 infections in Taiwan increased by about 30 percent last week, in the latest sign the country is entering a fourth wave of cases fueled by lineages ...05/23/2023 04:32 PM
- Taiwan to further ease mask rules at end of MaySome of Taiwan's last remaining mask rules, which require the wearing of masks in long-term care facilities and ambulances, are likely to be lifted on May 31, the Centers for ...05/16/2023 06:35 PM
- Updated Moderna booster shots available for young children starting May 16Children aged 6 months to 5 years who have already received two Moderna vaccine doses will be able to get a second-generation Moderna jab as a booster shot against COVID-19 ...05/12/2023 10:39 PM
Latest
- Politics
Taiwan congratulates Turkish President Erdogan on winning reelection
05/29/2023 12:59 PM - Society
2 Tainan girls wounded by dead wood while hiking
05/29/2023 11:51 AM - Politics
Taiwan's Navy set to take delivery of second homemade corvette next month
05/29/2023 10:32 AM - Business
U.S. dollar down in Taipei trading
05/29/2023 10:13 AM - Society
Taiwan headline news
05/29/2023 10:12 AM